Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 270

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Clinical practice guideline: Acute otitis externa

Rosenfeld, Richard M., Brown, Lance, Cannon, C. Ron, Dolor, Rowena J., Ganiats, Theodore G., Hannley, Maureen, Kokemueller, Phillip, Marcy, S. Michael, Roland, Peter S., Shiffman, Richard N., Stinnett, Sandra S., Witsell, David L. · 2006 · Otolaryngology–Head and Neck Surgery

Abstract

OBJECTIVE: This guideline provides evidence‐based recommendations to manage diffuse acute otitis externa (AOE), defined as generalized inflammation of the external ear canal, which may also involve the pinna or tympanic membrane. The primary purpose is to promote appropriate use of oral and topical antimicrobials and to highlight the need for adequate pain relief. STUDY DESIGN: In creating this guideline, the American Academy of Otolaryngology‐Head and Neck Surgery Foundation (AAO‐HNSF) selected a development group representing the fields of otolaryngology‐head and neck surgery, pediatrics, family medicine, infectious disease, internal medicine, emergency medicine, and medical informatics. The guideline was created with the use of an explicit, a priori, evidence‐based protocol. RESULTS: The group made a strong recommendation that management of AOE should include an assessment of pain, and the clinician should recommend analgesic treatment based on the severity of pain. The group made recommendations that clinicians should: 1) distinguish diffuse AOE from other causes of otalgia, otorrhea, and inflammation of the ear canal; 2) assess the patient with diffuse AOE for factors that modify management (nonintact tympanic membrane, tympanostomy tube, diabetes, immunocompromised state, prior radiotherapy); and 3) use topical preparations for initial therapy of diffuse, uncomplicated AOE; systemic antimicrobial therapy should not be used unless there is extension outside of the ear canal or the presence of specific host factors that would indicate a need for systemic therapy. The group made additional recommendations that: 4) the choice of topical antimicrobial therapy of diffuse AOE should be based on efficacy, low incidence of adverse events, likelihood of adherence to therapy, and cost; 5) clinicians should inform patients how to administer topical drops, and when the ear canal is obstructed, delivery of topical preparations should be enhanced by aural toilet, placing a wick, or both; 6) when the patient has a tympanostomy tube or known perforation of the tympanic membrane, the clinician should prescribe a nonototoxic topical preparation; and 7) if the patient fails to respond to the initial therapeutic option within 48 to 72 hours, the clinician should reassess the patient to confirm the diagnosis of diffuse AOE and to exclude other causes of illness. And finally, the panel compiled a list of research needs based on limitations of the evidence reviewed. CONCLUSION: This clinical practice guideline is not intended as a sole source of guidance in evaluating patients with AOE. Rather, it is designed to assist clinicians by providing an evidence‐based framework for decision‐making strategies. It is not intended to replace clinical judgment or establish a protocol for all individuals with this condition and may not provide the only appropriate approach to the diagnosis and management of this problem. SIGNIFICANCE: This is the first, explicit, evidence‐based clinical practice guideline on acute otitis externa, and the first clinical practice guideline produced independently by the AAO‐HNSF. © 2006 American Academy of Otolaryngology‐Head and Neck Surgery Foundation, Inc. All rights reserved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.otohns.2006.02.014

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 89

  1. 10.1177/00034894991080S201 · doi:10.1177/00034894991080s201
  2. 10.1017/S0022215100129469 · doi:10.1017/s0022215100129469
  3. 10.1097/00005537-200207000-00005 · doi:10.1097/00005537-200207000-00005
  4. 10.1016/S0163-4453(05)80004-0 · doi:10.1016/s0163-4453(05)80004-0
  5. Clark WB, 1997, Microbiology of otitis externa., Otolarngol Head Neck Surg, 116, 23
  6. 10.1001/archotol.1997.01900110047007 · doi:10.1001/archotol.1997.01900110047007
  7. 10.1097/00019048-199911000-00009 · doi:10.1097/00019048-199911000-00009
  8. Arshad M, 2004, Sensitivity and spectrum of bacterial isolates in infectious otitis externa., J Coll Physicians Surg Pak, 14, 146
  9. Hajioff D, 2004, Otitis externa., Clin Evid, 12, 755
  10. 10.1056/NEJM196302072680604 · doi:10.1056/nejm196302072680604
  11. 10.1046/j.1365-2273.2003.00713.x · doi:10.1046/j.1365-2273.2003.00713.x
  12. 10.5694/j.1326-5377.1992.tb139790.x · doi:10.5694/j.1326-5377.1992.tb139790.x
  13. Blake P, 1998, When not to syringe an ear., N Z Med J, 111, 422
  14. Berry RG, 1993, Otitis externa and facial cellulitis from Oriental ear cleaners., West J Med, 158, 536
  15. 10.1288/00005537-198407000-00020 · doi:10.1288/00005537-198407000-00020
  16. 10.1017/S0022215100124739 · doi:10.1017/s0022215100124739
  17. 10.1080/00039896.1982.10667583 · doi:10.1080/00039896.1982.10667583
  18. Hansen US, 1997, Otitis externa among users of private swimming pools., Ugeskr Laeger, 159, 4383
  19. Moore JE, 2002, Incidence of Pseudomonas aeruginosa in recreational and hydrotherapy pools., Commun Dis Public Health, 5, 23
  20. 10.2166/wst.2004.0020 · doi:10.2166/wst.2004.0020
  21. 10.1159/000276728 · doi:10.1159/000276728
  22. 10.1001/archotol.1996.01890200023004 · doi:10.1001/archotol.1996.01890200023004
  23. 10.1016/S0030-6665(20)30314-5 · doi:10.1016/s0030-6665(20)30314-5
  24. 10.1016/S0149-2918(99)80027-7 · doi:10.1016/s0149-2918(99)80027-7
  25. Kaushik V, 2004, Interventions for otitis externa (protocol)., Cochrane Database Syst Rev, 2, CD004740
  26. Lucente FE, 1995, External ear.
  27. 10.1111/j.1365-4362.1981.tb00817.x · doi:10.1111/j.1365-4362.1981.tb00817.x
  28. 10.1001/archderm.1973.01620250025006 · doi:10.1001/archderm.1973.01620250025006
  29. Larsson‐Styme B, 1985, Ear piercing: a cause of nickel allergy in schoolgirls?, Contact Dermatitis, 13, 268
  30. 10.1097/00003446-199204000-00009 · doi:10.1097/00003446-199204000-00009
  31. 10.3109/03005368709077787 · doi:10.3109/03005368709077787
  32. Schapowal A, 2001, Contact dermatitis to antibiotic ear drops is due to neomycin but not to ciprofloxacin [abstract]., Allergy, 56, 148
  33. 10.1258/00222150260293691 · doi:10.1258/00222150260293691
  34. 10.1258/0022215041615100 · doi:10.1258/0022215041615100
  35. 10.1177/014556130007900815 · doi:10.1177/014556130007900815
  36. 10.1016/S0305-7372(03)00066-5 · doi:10.1016/s0305-7372(03)00066-5
  37. 2001, Pain: current understanding of assessment, management and treatments.
  38. Valencia CG, 1987, Potassium diclofenac vs placebo in acute otitis externa: a double‐blind, comparative study [Spanish]., Invest Med Int, 14, 56
  39. 10.1017/S0022215100114252 · doi:10.1017/s0022215100114252
  40. 10.1136/bmj.327.7425.1201 · doi:10.1136/bmj.327.7425.1201
  41. 10.1017/S0022215100102178 · doi:10.1017/s0022215100102178
  42. Psifidis A, 2005, The efficacy and safety of local ciprofloxacin in patients with external otitis: a randomized comparative study., Mediterranean J Otol Audiol, 1
  43. 10.1177/000348949110000806 · doi:10.1177/000348949110000806
  44. Cannon SJ, 1967, Treatment of otitis externa with a topical steroid‐antibiotic combination: a controlled clinical trial., Eye Ear Nose Throat Monthly, 46, 1296
  45. Cannon S, 1970, External otitis: controlled therapeutic trial., Eye Ear Nose Throat Monthly, 49, 186
  46. Freedman R, 1978, Versus placebo in treatment of acute otitis externa., Ear Nose Throat J, 57, 198
  47. Pedersen CB, 1971, Otitis externa treated with locacortenvioform ear drops [Danish]., Ugeskrift for Laeger, 133, 389
  48. 10.5694/j.1326-5377.1993.tb121918.x · doi:10.5694/j.1326-5377.1993.tb121918.x
  49. Kime CE, 1978, Effective treatment of acute diffuse otitis externa: II. a controlled comparison of hydrocortisone‐acetic acid, nonaqueous and hydrocortisone‐neomycin‐colistin otic solutions., Curr Ther Res Clin Exp, 23, ss15
  50. Ordonez GE, 1978, Effective treatment of acute diffuse otitis externa: I. a controlled comparison of hydrocortisone‐acetic acid, non‐aqueous and hydrocortisone‐neomycin‐polymyxin B otic solutions., Curr Ther Res Clin Exp, 23, ss3
  51. 10.1111/j.1365-2273.1990.tb00425.x · doi:10.1111/j.1365-2273.1990.tb00425.x
  52. Lambert IJ, 1981, A comparison of the treatment of otitis externa with Otosporin and aluminium acetate: a report from a services practice in Cyprus., J Royal Col Gen Pract, 31, 291
  53. 10.1097/00007611-197705000-00011 · doi:10.1097/00007611-197705000-00011
  54. 10.1258/002221504772784513 · DOI
  55. 10.1097/00005537-200405000-00011 · doi:10.1097/00005537-200405000-00011
  56. 10.1007/BF00183171 · doi:10.1007/bf00183171
  57. 10.1258/0022215053945705 · doi:10.1258/0022215053945705
  58. Bak JP, 1983, Treatment of otitis externa with miconazole nitrate: a comparative study involving 85 cases., S Afr Med J, 63, 562
  59. 10.1046/j.1365-2273.2001.00455.x · doi:10.1046/j.1365-2273.2001.00455.x
  60. 10.1097/00007611-200405000-00010 · doi:10.1097/00007611-200405000-00010
  61. 10.1080/00913847.1991.11702213 · doi:10.1080/00913847.1991.11702213
  62. 10.1080/00913847.1986.11709152 · doi:10.1080/00913847.1986.11709152
  63. 10.1185/03007999309111548 · doi:10.1185/03007999309111548
  64. 10.1053/ajot.2002.123461 · doi:10.1053/ajot.2002.123461
  65. 10.1185/030079902125004312 · doi:10.1185/030079902125004312
  66. Sabater F, 1996, Prospective double‐blind randomized study of the efficacy and tolerance of topical ciprofloxacin vs topical gentamicin in the treatment of simple chronic otitis media and diffuse external otitis [Spanish]., Acta Otorrinolaryngol Esp, 47, 217
  67. 10.1016/j.ijporl.2005.01.022 · doi:10.1016/j.ijporl.2005.01.022
  68. 10.3109/00016488509126565 · doi:10.3109/00016488509126565
  69. 10.1111/j.1365-2273.1995.tb00052.x · doi:10.1111/j.1365-2273.1995.tb00052.x
  70. 10.1017/S0022215100123801 · doi:10.1017/s0022215100123801
  71. 10.1016/S0149-2918(04)90176-2 · doi:10.1016/s0149-2918(04)90176-2
  72. 10.1258/0022215053561495 · doi:10.1258/0022215053561495
  73. 10.1177/014556139607500906 · doi:10.1177/014556139607500906
  74. 10.1258/0022215001903834 · doi:10.1258/0022215001903834
  75. 10.1111/j.1365-2273.1994.tb01198.x · doi:10.1111/j.1365-2273.1994.tb01198.x
  76. 10.1016/0002-9343(88)90592-X · doi:10.1016/0002-9343(88)90592-x
  77. 10.1017/S0022215100113696 · doi:10.1017/s0022215100113696
  78. 10.1056/NEJM199109263251320 · doi:10.1056/nejm199109263251320
  79. 10.1258/0022215021911130 · doi:10.1258/0022215021911130
  80. 10.1097/00005537-200112000-00004 · doi:10.1097/00005537-200112000-00004
  81. 10.1080/000164801300043208 · doi:10.1080/000164801300043208
  82. 10.1016/j.otohns.2003.12.008 · doi:10.1016/j.otohns.2003.12.008
  83. Rakover Y, 1997, Safety of topical ear drops containing ototoxic antibiotics., J Otolaryngol, 26, 194
  84. Abello P, 1998, Topical ototoxicity: review over a 6‐year period [Spanish]., Acta Otorrinolaringol Esp, 49, 353
  85. Linder TE, 1995, Ototoxicity of ear drops: a clinical perspective., Am J Otol, 16, 653
  86. 2003, Cortisporin Otic Suspension Sterile package insert.
  87. 10.1097/00005537-200309000-00016 · doi:10.1097/00005537-200309000-00016
  88. Devos SA, 2000, The relevance of positive patch test reactions in chronic otitis externa., Contact Dermatitis, 42, 354
  89. 10.1177/01455613040839s408 · doi:10.1177/01455613040839s408

Cited by

Metadata

Authors
Rosenfeld, R. M., Brown, L., Cannon, C. R., Dolor, R. J., Ganiats, T. G., Hannley, M., Kokemueller, P., Marcy, S. M., Roland, P. S., Shiffman, R. N., Stinnett, S. S., & Witsell, D. L.
Venue
Otolaryngology–Head and Neck Surgery
Publisher
Wiley
Published
2006-04
Volume
134
Issue
S4
Pages
S1-S24
ISSN
  • 0161-6439 (ISSN-L)
  • 0194-5998
  • 1097-6817
OpenAlex
W2163398872
Cited by
270
References
59
FWCI
7.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.